{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:07:04Z","timestamp":1768522024874,"version":"3.49.0"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>A novel fusion gene <jats:italic>NRF1::PDGFRA<\/jats:italic> was identified in a patient with myeloid\/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions (MLN-TK), harboring the chromosome abnormality t(4;7)(q12;q32). This represents the first reported case of the <jats:italic>NRF1<\/jats:italic>::<jats:italic>PDGFRA<\/jats:italic> fusion gene, and the ninth <jats:italic>PDGFRA<\/jats:italic>-associated fusion gene identified in MLN-TK. The fusion event led to the constitutive activation of the PDGFRA kinase, resulting in uncontrolled eosinophil proliferation and potentially contributing to the occurrence of cerebral infarction. Our study indicates treatment with low-dose imatinib effectively alleviates the symptoms associated with <jats:italic>NRF1::PDGFRA<\/jats:italic> gene fusion.<\/jats:p>","DOI":"10.3389\/fonc.2025.1552928","type":"journal-article","created":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T21:47:55Z","timestamp":1742939275000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Identification of a novel NRF1::PDGFRA fusion in myeloid\/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions"],"prefix":"10.3389","volume":"15","author":[{"given":"Jialong","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaqing","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanfang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingnan","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junyan","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisha","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinying","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,3,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic\/Dendritic Neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022015850","article-title":"International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-023-01958-1","article-title":"Myeloid\/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions: reevaluation of the defining characteristics in a registry-based cohort","volume":"37","author":"Metzgeroth","year":"2023","journal-title":"Leukemia"},{"key":"B4","doi-asserted-by":"crossref","DOI":"10.36255\/exon-publications-leukemia-pdgfra-rearrangement","article-title":"Myeloid\/Lymphoid Neoplasms with Eosinophilia and Platelet Derived Growth Factor Receptor Alpha (PDGFRA) Rearrangement","volume-title":"Exon Publications","author":"Kaur","year":"2022"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa025217","article-title":"A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome","volume":"348","author":"Cools","year":"2003","journal-title":"N Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/11.12.1391","article-title":"The t(4;22)(q12;q11) in atypical chronic myeloid leukaemia fuses BCR to PDGFRA","volume":"11","author":"Baxter","year":"2002","journal-title":"Hum Mol Genet"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1206543","article-title":"Chronic myeloproliferative disorders with rearrangement of the platelet-derived growth factor alpha receptor: a new clinical target for STI571\/Glivec","volume":"22","author":"Trempat","year":"2003","journal-title":"Oncogene"},{"key":"B8","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/gcc.20014","article-title":"Molecular and cytogenetic characterization of a novel translocation t(4;22) involving the breakpoint cluster region and platelet-derived growth factor receptor-alpha genes in a patient with atypical chronic myeloid leukemia","volume":"40","author":"Safley","year":"2004","journal-title":"Genes Chromosomes Cancer"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404154","article-title":"Identification of a novel imatinib responsive KIF5B-PDGFRA fusion gene following screening for PDGFRA overexpression in patients with hypereosinophilia","volume":"20","author":"Score","year":"2006","journal-title":"Leukemia"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.20359","article-title":"Transient response to imatinib in a chronic eosinophilic leukemia associated with ins(9;4)(q33;q12q25) and a CDK5RAP2-PDGFRA fusion gene","volume":"45","author":"Walz","year":"2006","journal-title":"Genes Chromosomes Cancer"},{"key":"B11","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/j.1365-2141.2007.06628.x","article-title":"Two novel imatinib-responsive PDGFRA fusion genes in chronic eosinophilic leukaemia","volume":"138","author":"Curtis","year":"2007","journal-title":"Br J Haematol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.cancergen.2015.07.001","article-title":"A novel FOXP1-PDGFRA fusion gene in myeloproliferative neoplasm with eosinophilia","volume":"208","author":"Sugimoto","year":"2015","journal-title":"Cancer Genet"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.lrr.2024.100465","article-title":"Acute myeloid leukemia with a novel AKAP9::PDGFRA fusion transformed from essential thrombocythemia: A case report and mini review","volume":"21","author":"Sahin","year":"2024","journal-title":"Leuk Res Rep"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2017.05.014","article-title":"Transcribing \u03b2-cell mitochondria in health and disease","volume":"6","author":"Mulder","year":"2017","journal-title":"Mol Metab"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/29.1.303","article-title":"Atlas of Genetics and Cytogenetics in Oncology and Haematology, updated","volume":"29","author":"Huret","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkab1056","article-title":"FusionGDB 2.0: fusion gene annotation updates aided by deep learning","volume":"50","author":"Kim","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-016-1616-3","article-title":"Activating NRF1-BRAF and ATG7-RAF1 fusions in anaplastic pleomorphic xanthoastrocytoma without BRAF p.V600E mutation","volume":"132","author":"Phillips","year":"2016","journal-title":"Acta Neuropathol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1101\/mcs.a003848","article-title":"Urothelial carcinoma with an NRF1-BRAF rearrangement and response to targeted therapy","volume":"5","author":"Isaacson","year":"2019","journal-title":"Cold Spring Harb Mol Case Stud"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1210\/me.2007-0029","article-title":"Estradiol stimulates transcription of nuclear respiratory factor-1 and increases mitochondrial biogenesis","volume":"22","author":"Mattingly","year":"2008","journal-title":"Mol Endocrinol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-018-0792-2","article-title":"Receptor tyrosine kinases and downstream pathways as druggable targets for cancer treatment: the current arsenal of inhibitors","volume":"17","author":"Montor","year":"2018","journal-title":"Mol Cancer"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/978-94-007-0344-5_12","article-title":"Malignant gliomas: role of platelet-derived growth factor receptor A (PDGFRA)","volume":"1","author":"Martinho","year":"2011","journal-title":"Tumors Cent Nervous System Volume 1: Gliomas: Glioblastoma (Part 1)"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-06-1824","article-title":"The\u00a0FIP1L1-PDGFRalpha fusion tyrosine kinase in hypereosinophilic syndrome\u00a0and\u00a0chronic eosinophilic leukemia: implications for diagnosis, classification, and management","volume":"103","author":"Gotlib","year":"2004","journal-title":"Blood"},{"key":"B23","article-title":"Case Report Eosinophilia complicated with cerebral infarction: a case report and literature review","volume":"16","author":"Jia","year":"2023","journal-title":"Int J Clin Exp Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2010.256","article-title":"Cerebral infarcts in the setting of eosinophilia: three cases and a discussion","volume":"67","author":"Sethi","year":"2010","journal-title":"Arch Neurol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcha.2021.100915","article-title":"Literature reviews of stroke with hypereosinophilic syndrome","volume":"37","author":"Ono","year":"2021","journal-title":"Int J Cardiol Heart Vasc"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1552928\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T21:48:06Z","timestamp":1742939286000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1552928\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,25]]},"references-count":25,"alternative-id":["10.3389\/fonc.2025.1552928"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1552928","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,25]]},"article-number":"1552928"}}